LNSR LENSAR Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: LNSR

Price (delayed)

$5.61

Market cap

$67.91M

P/E Ratio

5.72

Dividend/share

N/A

EPS

$0.98

Enterprise value

$57.99M

Sign up for free to view scoring metrics ?
Relative Growth: Rel. Growth:
Relative Strength: Rel. Strength:
Relative Valuation: Rel. Valuation:
Relative Profitability: Rel. Profitability: 50

LENSAR is a commercial-stage medical device company focused on designing, developing and marketing an advanced femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically ...

Highlights
LENSAR's net income has surged by 186% QoQ and by 152% YoY
The equity has soared by 149% YoY and by 141% from the previous quarter
LENSAR's quick ratio has surged by 72% QoQ but it has decreased by 13% YoY
LENSAR's debt has decreased by 6% from the previous quarter but it has increased by 4.1% YoY
LENSAR's gross margin has decreased by 4.6% YoY
LENSAR's gross profit has decreased by 3.4% YoY and by 2.7% from the previous quarter
Sector: Healthcare
Industry: Medical Devices
Website: http://www.lensar.com
Peers: OBIO OM

Key stats

What are the main financial stats of LNSR

LNSR stock price

How has the LENSAR stock price performed over time
Intraday
-2.26%
1 week
-6.5%
1 month
0.9%
1 year
-58.48%
YTD
-51.76%
QTD
-5.87%

Financial performance

How have LENSAR's revenue and profit performed over time
Revenue
$57.7M
Gross profit
$26.38M
Operating income
-$16.55M
Net income
$29.39M
Gross margin
45.7%
Net margin
50.9%
LENSAR's net margin has soared by 187% from the previous quarter and by 151% YoY
LENSAR's net income has surged by 186% QoQ and by 152% YoY
The operating income has grown by 33% from the previous quarter but it has contracted by 22% YoY
LENSAR's operating margin has increased by 32% from the previous quarter but it has decreased by 21% YoY

Price vs fundamentals

How does LNSR's price correlate with its fundamentals

Growth

What is LENSAR's growth rate over time

Valuation

What is LENSAR stock price valuation
P/E
5.72
P/B
6.29
P/S
1.18
EV/EBIT
1.97
EV/EBITDA
1.68
EV/Sales
1
The EPS has soared by 134% QoQ and by 120% YoY
The equity has soared by 149% YoY and by 141% from the previous quarter
The P/B is 114% above the 5-year quarterly average of 3.0
LNSR's P/S is 45% below its last 4 quarters average of 2.2 and 29% below its 5-year quarterly average of 1.7

Efficiency

How efficient is LENSAR business performance
The ROA has soared by 188% from the previous quarter and by 149% YoY
The ROS has soared by 187% QoQ and by 151% YoY
The ROIC has soared by 177% QoQ and by 164% YoY

Dividends

What is LNSR's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for LNSR.

Financial health

How did LENSAR financials performed over time
The total assets is 59% more than the total liabilities
The current ratio has soared by 107% since the previous quarter and by 31% year-on-year
LENSAR's quick ratio has surged by 72% QoQ but it has decreased by 13% YoY
LENSAR's debt is 76% less than its equity
The equity has soared by 149% YoY and by 141% from the previous quarter
LENSAR's debt has decreased by 6% from the previous quarter but it has increased by 4.1% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.